Christopher Koh MD MHSc
Hepatology & Liver Transplantation
Clinical Director, NIDDK, NIH
Join to View Full Profile
10 Center DrCrc Bldg-10, Rm. 5-2740Bethesda, MD 20892
Phone+1 301-443-9402
Dr. Koh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandFellowship, Gastroenterology, 2010 - 2013
Duke University School Of MedicineMHSc, Clinical Research, 2009 - 2012
NIH Clinical Center2007 - 2010
MedStar Health Georgetown University/Harbor HospitalChief Residency, Internal Medicine, 2006 - 2007- MedStar Health Georgetown University/Harbor HospitalResidency, Internal Medicine, 2004 - 2007
Saba University School of MedicineClass of 2004
Certifications & Licensure
MD State Medical License 2007 - 2026
Clinical Trials
- Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C Start of enrollment: 2014 Mar 20
Publications & Presentations
PubMed
- Clinical and Genetic Associations in Cephalosporin-Induced Liver Injury: Insights From the Drug-Induced Liver Injury Network.Raj Vuppalanchi, Yi-Ju Li, Don C Rockey, Dina Halegoua-DeMarzio, Robert J Fontana
Alimentary Pharmacology & Therapeutics. 2025-07-20 - Gastrointestinal complaints in patients with osteogenesis imperfecta: The bright side of a rare genetic disorder.Disha Sharma, Gracia M Viana Rodriguez, Chunwei Walter Lai, Bilal Asif, Sara Talvacchio
Bone. 2025-07-09 - Portal sinusoidal vascular diseases: Assessment and therapy.Maria Mironova, Harish Gopalakrishna, Christopher Koh, David E Kleiner, Theo Heller
Hepatology. 2025-04-04
Press Mentions
Superior Athleticism: Is It in Your Genes? By Colleen LabbeJuly 31st, 2015
Eiger Biopharmaceuticals Enrolls First Patient in Trial for Hepatitis D TherapyAugust 10th, 2018
Risk Factors Can Help Spot People Who Need Hep D ScreeningNovember 17th, 2020
Grant Support
- Multidisciplinary Collaborative Clinical Research, Protocol Navigation, Monitoring Compliance, and Other Clinical Services in NIDDK Program Area DiseasesNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
- Management and Treatment of Chronic Delta Hepatitis Infection and other Liver DiseasesNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
- Management and Treatment of Chronic Delta Hepatitis Infection and other Liver DiseasesNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
Professional Memberships
- Member
- Member
- American Association For The Study Of Liver DiseasesMember
Other Languages
- Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
